Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
196
days
Efficacy, Safety, Quality of Life, and Adherence of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review
Authors
Jacob Surma; Jenna Currier; David Doyle; Mackenzy Maddock; Garrett Borgman; Cassandra DeGroat; Sierra Demarinis; Natalie Aguilar; Spencer Williams; Patrick Fakhoury; Robert StachlerShow moreShow less
Affiliations
1. Covenant Healthcare College of Medicine at Central Michigan University, Saginaw, USA; 2. Stachler ENT, West Bloomfield, USAShow moreShow less
130
days
Optimizing Amiodarone Maintenance Dose to Minimize N-Desethylamiodarone Accumulation and Pulmonary Toxicity: Insights from Machine Learning and Pharmacokinetic Simulation
Authors
Minori Teraguchi; Toshiaki Komatsu; Yuto Akamada; Takeru Nabeta; Hidehira Fukaya; Junya Ako; Katsuya OtoriShow moreShow less
Affiliations
1. Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan; 2. Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan; 3. Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Sagamihara, JapanShow moreShow less
344
days
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants
Authors
Eva-Maria Sunzel; Giulia Ghibellini; Maria Gutierrez; Debra Ruffo; Shailendra Chavan; Nagnath G. Birajdar; Frank Schneider; Pippa Loupe; Mark Forrest Gordon; Laura Rabinovich-GuilattShow moreShow less
Affiliations
1. Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, West Chester, USA; 2. Teva Clinics, Miramar, USA; 3. Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, India; 4. Teva Pharmaceutical Industries Ltd, Ratiopharm GmbH, Ulm, Germany; 5. Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, Netanya, IsraelShow moreShow less
341
days
Ketamine and Evolving Neuroplasticity
Authors
Angel PrabakarShow moreShow less
Affiliations
1. Stony Brook University, Stony Brook, USAShow moreShow less
110
days
Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification
Authors
Ozlem TotukShow moreShow less
Affiliations
1. Department of Neurology, University of Health Sciences, Hamidiye Faculty of Medicine, Sancaktepe Sehit Prof. Dr. İlhan Varank Training and Hospital, Istanbul, TurkeyShow moreShow less
208
days
Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach
Authors
Ahmed S. Kenawy; James O. Baffoe; Chanhyun ParkShow moreShow less
Affiliations
1. Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days